Robinson Pharma, Inc. Successfully Completed Initial Implementation of Vegetarian Softgel Encapsulation
May 05, 2015
May 5th, 2015 – Costa Mesa, CA – Robinson Pharma, Inc. is pleased to announce the completion of the implementation phase of vegetarian softgel encapsulation capabilities to its already robust array of dosage forms. Accomplishment of this encapsulation-production benchmark, which features a patented starch and carrageenan vegetarian gel matrix, is a key event in Robinson Pharma’s ongoing commitment to supporting client demands. The next step is commercialization of this advanced production process, which will be achieved in the coming months.
“Vegetarian softgels have correctly been perceived as having a delicate and complicated production process until now,” stated VP of R&D, Rebecca Montes. “Robinson Pharma has implemented some unique, proprietary engineering and equipment solutions to overcome the many traditional challenges in this process, facilitating greater productivity, efficiency, speed, reliability, yield, and robustness. Just as Robinson Pharma revolutionized traditional (animal-derived) softgel production with the first-ever implementation of continuous drying softgel processing, our team has rethought and re-equipped the vegetarian softgel process, allowing us to offer our clients a better vegetarian softgel at a more competitive price.” Vegetarian softgels offer a number of distinct advantages to both marketers and end users of dietary supplement softgels. Robinson Pharma intends to initiate commercialization with basic oil fillings in clear gelatin before introducing features such as colored shells as manufacturing progresses.
Robinson Pharma is a Southern-California based, full-service contract manufacturer of dietary supplements. It has a state-issued drug manufacturing license and maintains more third-party certifications for current Good Manufacturing Practice (cGMP) compliance than any other facility, with certifications from NPA, NSF, and UL. Robinson Pharma features the largest softgel encapsulation capacity in the US—with 20 continuous drying encapsulation lines capable of producing over 12 billion softgels per year—and maintains 400,000 square feet of production, operations, and warehousing facilities. Production capabilities also include tablet compression, capsule filling, cosmetic products, liquid formulations, powder blending, enteric coating of softgels and tablets, and custom imprinting on softgels; plus a wide range of packaging options including bottles, blister packaging, sachets, boxing, and bulk products. Additional services include product development and ingredient sourcing. For more information on Robinson Pharma’s vegetarian softgels please visit: http://robinsonpharma.com/Capabilities/Supplement-Manufacturer-With-Largest-Capacity-Of-Vegetarian-Softgels or email Info@RobinsonPharma.com
Return to News